Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
115807094 | 11580709 | 4 | F | 20160721 | 20160812 | 20150930 | 20160822 | EXP | CA-ABBVIE-15K-028-1471671-00 | ABBVIE | 43.00 | YR | F | Y | 0.00000 | 20160822 | OT | CA | CA |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
115807094 | 11580709 | 1 | PS | HUMIRA | ADALIMUMAB | 1 | Subcutaneous | N | UNKNOWN | 125057 | |||||||||
115807094 | 11580709 | 2 | SS | REMICADE | INFLIXIMAB | 1 | Unknown | N | UNKNOWN | 0 | |||||||||
115807094 | 11580709 | 3 | SS | ACTEMRA | TOCILIZUMAB | 1 | Unknown | N | UNKNOWN | 0 | |||||||||
115807094 | 11580709 | 4 | SS | ORENCIA | ABATACEPT | 1 | Unknown | N | UNKNOWN | 0 | |||||||||
115807094 | 11580709 | 5 | SS | CIMZIA | CERTOLIZUMAB PEGOL | 1 | Unknown | N | UNKNOWN | 0 | |||||||||
115807094 | 11580709 | 6 | SS | ENBREL | ETANERCEPT | 1 | Unknown | N | UNKNOWN | 0 | |||||||||
115807094 | 11580709 | 7 | SS | RITUXAN | RITUXIMAB | 1 | Unknown | N | UNKNOWN | 0 | |||||||||
115807094 | 11580709 | 8 | SS | SIMPONI | GOLIMUMAB | 1 | Unknown | N | UNKNOWN | 0 | |||||||||
115807094 | 11580709 | 9 | SS | ARAVA | LEFLUNOMIDE | 1 | Unknown | N | UNKNOWN | 0 | |||||||||
115807094 | 11580709 | 10 | SS | PLAQUENIL | HYDROXYCHLOROQUINE SULFATE | 1 | Unknown | N | UNKNOWN | 0 | |||||||||
115807094 | 11580709 | 11 | SS | SULFASALAZINE. | SULFASALAZINE | 1 | Unknown | N | UNKNOWN | 0 | |||||||||
115807094 | 11580709 | 12 | SS | METHOTREXATE. | METHOTREXATE | 1 | Unknown | UNKNOWN | 0 | ||||||||||
115807094 | 11580709 | 13 | SS | FOLIC ACID. | FOLIC ACID | 1 | Unknown | UNKNOWN | 0 | ||||||||||
115807094 | 11580709 | 14 | SS | PREDNISONE. | PREDNISONE | 1 | Unknown | UNKNOWN | 0 | ||||||||||
115807094 | 11580709 | 15 | SS | FOSAMAX | ALENDRONATE SODIUM | 1 | Unknown | UNKNOWN | 0 | ||||||||||
115807094 | 11580709 | 16 | SS | REACTINE | CETIRIZINE HYDROCHLORIDE | 1 | Unknown | UNKNOWN | 0 | ||||||||||
115807094 | 11580709 | 17 | SS | CORTISONE | CORTISONEHYDROCORTISONE | 1 | Oral | N | UNKNOWN | 0 | ORAL DROPS | ||||||||
115807094 | 11580709 | 18 | C | HYDROXYCHLOROQUINE | HYDROXYCHLOROQUINE | 1 | 0 | ||||||||||||
115807094 | 11580709 | 19 | C | XELJANZ | TOFACITINIB CITRATE | 1 | 0 |
Indications of drugs used
Event ID | CASEID | INDI DRUG SEQ | INDI PT |
---|---|---|---|
115807094 | 11580709 | 1 | Rheumatoid arthritis |
115807094 | 11580709 | 2 | Rheumatoid arthritis |
115807094 | 11580709 | 3 | Rheumatoid arthritis |
115807094 | 11580709 | 4 | Rheumatoid arthritis |
115807094 | 11580709 | 5 | Rheumatoid arthritis |
115807094 | 11580709 | 6 | Rheumatoid arthritis |
115807094 | 11580709 | 7 | Rheumatoid arthritis |
115807094 | 11580709 | 8 | Rheumatoid arthritis |
115807094 | 11580709 | 9 | Rheumatoid arthritis |
115807094 | 11580709 | 10 | Rheumatoid arthritis |
115807094 | 11580709 | 11 | Rheumatoid arthritis |
115807094 | 11580709 | 12 | Rheumatoid arthritis |
115807094 | 11580709 | 13 | Rheumatoid arthritis |
115807094 | 11580709 | 14 | Rheumatoid arthritis |
115807094 | 11580709 | 15 | Rheumatoid arthritis |
115807094 | 11580709 | 16 | Rheumatoid arthritis |
115807094 | 11580709 | 17 | Rheumatoid arthritis |
115807094 | 11580709 | 18 | Product used for unknown indication |
115807094 | 11580709 | 19 | Product used for unknown indication |
Outcome of event
Event ID | CASEID | OUTC COD |
---|---|---|
115807094 | 11580709 | OT |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
115807094 | 11580709 | Abdominal discomfort | |
115807094 | 11580709 | Alopecia | |
115807094 | 11580709 | Anti-cyclic citrullinated peptide antibody positive | |
115807094 | 11580709 | Drug ineffective | |
115807094 | 11580709 | Drug intolerance | |
115807094 | 11580709 | Fatigue | |
115807094 | 11580709 | Glossodynia | |
115807094 | 11580709 | Hand deformity | |
115807094 | 11580709 | Hip arthroplasty | |
115807094 | 11580709 | Infusion related reaction | |
115807094 | 11580709 | Joint swelling | |
115807094 | 11580709 | Knee arthroplasty | |
115807094 | 11580709 | Pain | |
115807094 | 11580709 | Pemphigus | |
115807094 | 11580709 | Rash | |
115807094 | 11580709 | Rheumatoid factor positive | |
115807094 | 11580709 | Swelling | |
115807094 | 11580709 | Systemic lupus erythematosus | |
115807094 | 11580709 | Wound |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
no results found |